Transcatheter Structural Heart Device Market by Type and Application- Global Industry Analysis & Forecast to 2027

Published On : September 2020 Pages : 170 Category: Medical Devices Report Code : HC0912682

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Transcatheter Structural Heart Device Market By Type (Left Atrial Appendage Occluders, Septal Defect Occluders, Aortic Valve Replacement, Mitral Valve Repair, Mitral Valve Replacement (Experimental)) and Application (Congenital Heart Defects, Aortic Stenosis, Mitral Regurgitation, Stroke, Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Transcatheter Structural Heart Device Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Transcatheter Structural heart device is used in an aortic valve replacement to replace a narrowed aortic valve that fails to open properly (aortic valve stenosis) and relieve the signs and symptoms of aortic valve stenosis and may improve survival in people who have severe symptoms.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Transcatheter Structural Heart Device Marketsize market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Medtronic
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • Micro Interventional Devices
  • Abbott
  • Neovasc
  • BraileBiomedica
  • Lifetech
  • Cryolife

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Transcatheter Structural Heart Device Market, ByType, Estimates and Forecast, 2017-2027 ($Million)

o    Left Atrial Appendage Occluders

o    Septal Defect Occluders

o    Aortic Valve Replacement

o    Mitral Valve Repair

o    Mitral Valve Replacement (Experimental)

·         Transcatheter Structural Heart Device Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Congenital Heart Defects

o    Aortic Stenosis

o    Mitral Regurgitation

o    Stroke

o    Others

·         Transcatheter Structural Heart Device Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Medtronic

o    LivaNova PLC

o    Edwards Lifesciences Corporation

o    Boston Scientific Corporation

o    Micro Interventional Devices

o    Abbott

o    Neovasc

o    BraileBiomedica

o    Lifetech

o    Cryolife

·         Transcatheter Structural Heart Device Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Transcatheter Structural Heart Device Market , By Country

o    U.S. Transcatheter Structural Heart Device Market

o    Canada Transcatheter Structural Heart Device Market

o    Mexico Transcatheter Structural Heart Device Market

o    Europe

§  Europe Transcatheter Structural Heart Device Market , By Country

o    UK Transcatheter Structural Heart Device Market

o    Germany Transcatheter Structural Heart Device Market

o    France Transcatheter Structural Heart Device Market

o    Russia Transcatheter Structural Heart Device Market

o    Italy Transcatheter Structural Heart Device Market

o    Rest of Europe Transcatheter Structural Heart Device Market

o    Asia-Pacific

§  Asia-Pacific Transcatheter Structural Heart Device Market , By Country

o    China Transcatheter Structural Heart Device Market

o    Japan Transcatheter Structural Heart Device Market

o    South Korea Transcatheter Structural Heart Device Market

o    India Transcatheter Structural Heart Device Market

o    Southeast Asia Transcatheter Structural Heart Device Market

o    Rest of Asia-Pacific Transcatheter Structural Heart Device Market

o    South America

§  South America Transcatheter Structural Heart Device Market

o    Brazil Transcatheter Structural Heart Device Market

o    Argentina Transcatheter Structural Heart Device Market

o    Columbia Transcatheter Structural Heart Device Market

o    Rest of South America Transcatheter Structural Heart Device Market

o    Middle East and Africa

§  Middle East and Africa Transcatheter Structural Heart Device Market

o    Saudi Arabia Transcatheter Structural Heart Device Market

o    UAE Transcatheter Structural Heart Device Market

o    Egypt Transcatheter Structural Heart Device Market

o    Nigeria Transcatheter Structural Heart Device Market

o    South Africa Transcatheter Structural Heart Device Market

o    Rest of MEA Transcatheter Structural Heart Device Market

 

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Transcatheter Structural Heart Device  Market, By Type

5.1.     Introduction

5.2.     Global Transcatheter Structural Heart Device  Revenue and Market Share by Type (2017-2021)

5.2.1.  Global Transcatheter Structural Heart Device  Revenue and Revenue Share by Type (2017-2021)

5.3.     Left Atrial Appendage Occluders

5.3.1.  Global Left Atrial Appendage Occluders Revenue and Growth Rate (2017-2021)

5.4.     Septal Defect Occluders

5.4.1.  Global Septal Defect Occluders Revenue and Growth Rate (2017-2021)

5.5.     Aortic Valve Replacement

5.5.1.  Global Aortic Valve Replacement Revenue and Growth Rate (2017-2021)

5.6.     Aortic Valve Replacement

5.6.1.  Global Aortic Valve Replacement Revenue and Growth Rate (2017-2021)

5.7.     Mitral Valve Replacement (Experimental)

5.7.1.  Global Mitral Valve Replacement (Experimental) Revenue and Growth Rate (2017-2021)

6.       Transcatheter Structural Heart Device  Market, By Applications

6.1.     Introduction

6.2.     Global Transcatheter Structural Heart Device  Revenue and Market Share by Applications (2017-2021)

6.2.1.  Global Transcatheter Structural Heart Device  Revenue and Revenue Share by Applications (2017-2021)

6.3.     Congenital Heart Defects

6.3.1.  Global Congenital Heart Defects Revenue and Growth Rate (2017-2021)

6.4.     Aortic Stenosis

6.4.1.  Global Aortic Stenosis Revenue and Growth Rate (2017-2021)

6.5.     Mitral Regurgitation

6.5.1.  Global Mitral Regurgitation Revenue and Growth Rate (2017-2021)

6.6.     Stroke

6.6.1.  Global Stroke Revenue and Growth Rate (2017-2021)

6.7.     Others

6.7.1.  Global Others Revenue and Growth Rate (2017-2021)

7.       Transcatheter Structural Heart Device  Market, By Region

7.1.     Introduction

7.2.     Global Transcatheter Structural Heart Device  Revenue and Market Share by Regions

7.2.1.  Global Transcatheter Structural Heart Device  Revenue by Regions (2017-2021)

7.3.     North America Transcatheter Structural Heart Device  by Countries

7.3.1.  North America Transcatheter Structural Heart Device  Revenue and Growth Rate (2017-2021)

7.3.2.  North America Transcatheter Structural Heart Device  Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Transcatheter Structural Heart Device  by Countries

7.4.1.  Europe Transcatheter Structural Heart Device  Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Transcatheter Structural Heart Device  Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Transcatheter Structural Heart Device  by Countries

7.5.1.  Asia-Pacific Transcatheter Structural Heart Device  Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Transcatheter Structural Heart Device  Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Transcatheter Structural Heart Device  by Countries

7.6.1.  South America Transcatheter Structural Heart Device  Revenue and Growth Rate (2017-2021)

7.6.2.  South America Transcatheter Structural Heart Device  Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Transcatheter Structural Heart Device  by Countries

7.7.1.  Middle East and Africa Transcatheter Structural Heart Device  Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Transcatheter Structural Heart Device  Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     Medtronic

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     LivaNova PLC

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Edwards Lifesciences Corporation

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Boston Scientific Corporation

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Micro Interventional Devices

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Abbott

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Neovasc

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Braile Biomedica

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Lifetech

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Cryolife

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.1.     Global Transcatheter Structural Heart Device  Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Transcatheter Structural Heart Device  Market Forecast by Regions (2022-2027)

9.2.1.  North America Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.1.1.  United States Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.1.2.  Canada Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.1.3.  Mexico Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.2.  Europe Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.2.1.  Germany Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.2.2.  France Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.2.3.  UK Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.2.4.  Russia Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.2.5.  Italy Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.3.1.  China Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.3.2.  Japan Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.3.3.  Korea Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.3.4.  India Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.4.  South America Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.4.1.  Brazil Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.4.2.  Argentina Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.4.3.  Columbia Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.4.4.  Rest of South America Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.5.3.  Egypt Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.5.4.  Nigeria Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.5.5.  South Africa Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.5.6.  Turkey Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa Transcatheter Structural Heart Device  Market Forecast (2022-2027)

9.3.     Transcatheter Structural Heart Device  Market Forecast by Type (2022-2027)

9.3.1.  Transcatheter Structural Heart Device  Forecast by Type (2022-2027)

9.3.2.  Transcatheter Structural Heart Device  Market Share Forecast by Type (2022-2027)

9.4.     Transcatheter Structural Heart Device  Market Forecast by Applications (2022-2027)

9.4.1.  Transcatheter Structural Heart Device  Forecast by Applications (2022-2027)

9.4.2.  Transcatheter Structural Heart Device  Market Share Forecast by Applications (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Transcatheter Structural Heart Device Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Transcatheter Structural Heart Device Revenue and Revenue Share by Type (2017-2019)
Figure Global Left Atrial Appendage Occluders Revenue and Growth Rate (2017-2019)
Figure Global Septal Defect Occluders Revenue and Growth Rate (2017-2019)
Figure Global Aortic Valve Replacement Revenue and Growth Rate (2017-2019)
Figure Global Aortic Valve Replacement Revenue and Growth Rate (2017-2019)
Figure Global Mitral Valve Replacement (Experimental) Revenue and Growth Rate (2017-2019)
Table Global Transcatheter Structural Heart Device Revenue and Revenue Share by Applications (2017-2019)
Figure Global Congenital Heart Defects Revenue and Growth Rate (2017-2019)
Figure Global Aortic Stenosis Revenue and Growth Rate (2017-2019)
Figure Global Mitral Regurgitation Revenue and Growth Rate (2017-2019)
Figure Global Stroke Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Transcatheter Structural Heart Device Revenue by Regions (2017-2019)
Figure North America Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure North America Transcatheter Structural Heart Device Revenue and Growth Rate (2017-2019)
Figure North America Transcatheter Structural Heart Device by Countries (2017-2019)
Figure North America Transcatheter Structural Heart Device Revenue (Million USD) by Countries (2017-2019)
Figure United States Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure United States Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Canada Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Mexico Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Europe Transcatheter Structural Heart Device Revenue and Growth Rate (2017-2019)
Figure Europe Transcatheter Structural Heart Device by Countries (2017-2019)
Figure Europe Transcatheter Structural Heart Device Revenue (Million USD) by Countries (2017-2019)
Figure Germany Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Germany Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure France Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure UK Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Russia Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Italy Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Rest of Europe Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Asia-Pacific Transcatheter Structural Heart Device Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Transcatheter Structural Heart Device by Countries (2017-2019)
Figure Asia-Pacific Transcatheter Structural Heart Device Revenue (Million USD) by Countries (2017-2019)
Figure China Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure China Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Japan Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Korea Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure India Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Southeast Asia Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure South America Transcatheter Structural Heart Device Revenue and Growth Rate (2017-2019)
Figure South America Transcatheter Structural Heart Device by Countries (2017-2019)
Figure South America Transcatheter Structural Heart Device Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Brazil Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Argentina Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Columbia Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Rest of South America Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Middle East and Africa Transcatheter Structural Heart Device Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Transcatheter Structural Heart Device by Countries (2017-2019)
Figure Middle East and Africa Transcatheter Structural Heart Device Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Saudi Arabia Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure United Arab Emirates Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Egypt Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Nigeria Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure South Africa Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Turkey Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Transcatheter Structural Heart Device Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2017-2019)
Table Medtronic Transcatheter Structural Heart Device Financial Overview
Table LivaNova PLC Transcatheter Structural Heart Device Financial Overview
Table Edwards Lifesciences Corporation Transcatheter Structural Heart Device Financial Overview
Table Boston Scientific Corporation Transcatheter Structural Heart Device Financial Overview
Table Micro Interventional Devices Transcatheter Structural Heart Device Financial Overview
Table Abbott Transcatheter Structural Heart Device Financial Overview
Table Neovasc Transcatheter Structural Heart Device Financial Overview
Table Braile Biomedica Transcatheter Structural Heart Device Financial Overview
Table Lifetech Transcatheter Structural Heart Device Financial Overview
Table Cryolife Transcatheter Structural Heart Device Financial Overview
Figure Global Transcatheter Structural Heart Device Revenue (Millions USD) and Growth Rate (2019-2027)
Table Transcatheter Structural Heart Device Market Forecast by Regions (2019-2027)
Figure North America Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure United States Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Canada Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Mexico Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Europe Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Germany Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure France Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure UK Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Russia Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Italy Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Rest of Europe Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Asia-Pacific Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure China Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Japan Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Korea Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure India Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Southeast Asia Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure South America Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Brazil Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Argentina Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Columbia Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Rest of South America Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Middle East and Africa Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Saudi Arabia Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure United Arab Emirates Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Egypt Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Nigeria Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure South Africa Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Turkey Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Transcatheter Structural Heart Device Market Forecast (2019-2027)
Figure Global Transcatheter Structural Heart Device Forecast by Type (2019-2027)
Figure Global Transcatheter Structural Heart Device Market Share Forecast by Type (2019-2027)
Figure Global Transcatheter Structural Heart Device Forecast by Type (2019-2027)
Figure Global Transcatheter Structural Heart Device Forecast by Applications (2019-2027)
Figure Global Transcatheter Structural Heart Device Market Share Forecast by Applications (2019-2027)
Figure Global Transcatheter Structural Heart Device Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country